Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

v3.20.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Non-Controlling Interest
Total
Beginning balance, shares at Mar. 31, 2018 0 0 97,656,095        
Beginning balance, amount at Mar. 31, 2018 $ 0 $ 0 $ 9,766 $ 27,743,352 $ (34,012,864) $ 0 $ (6,259,746)
Issuance of shares in connection with debt, shares     3,225,000        
Issuance of shares in connection with debt, amount     $ 323 106,628     106,951
Issuance of shares for cash, shares     220,000        
Issuance of shares for cash, amount     $ 22 15,378     15,400
Issuance of shares upon conversion, shares     226,217,349        
Issuance of shares upon conversion, amount     $ 22,623 1,338,275     1,360,898
Issuance of shares under equity financing agreement, shares     22,131,893        
Issuance of shares under equity financing agreement, amount     $ 2,213 462,303     464,516
Conversion of common shares into Series A preferred shares, shares 5,000,000   (75,000,000)        
Conversion of common shares into Series A preferred shares, amount $ 500   $ (7,500) 7,000     0
Beneficial conversion feature       620,977     620,977
Reclass of derivative liability upon conversion or redemption of related convertible debentures       4,068,500     4,068,500
Issuance of shares upon exercise of warrants, shares     27,307,955        
Issuance of shares upon exercise of warrants, amount     $ 2,731 3,973,369     3,976,099
Net loss (7,210,581) (7,210,581)
Ending balance, shares at Mar. 31, 2019 5,000,000 0 301,758,293        
Ending balance, amount at Mar. 31, 2019 $ 500 $ 0 $ 30,177 38,335,782 (41,223,445) 0 (2,856,986)
Issuance of shares upon conversion, shares     63,239,585        
Issuance of shares upon conversion, amount     $ 6,323 633,386     639,710
Issuance of shares under equity financing agreement, shares     14,744,646        
Issuance of shares under equity financing agreement, amount     $ 1,474 1,772,526     1,774,000
Purchase of Series B preferred shares, shares   2,250          
Purchase of Series B preferred shares, amount       2,250,000     2,250,000
Beneficial conversion feature related to the Series B preferred shares       475,000 (475,000)   0
Beneficial conversion feature       58,548     58,548
Reclass of derivative liability upon conversion or redemption of related convertible debentures       8,000     8,000
Net loss (4,728,951) (82,101) (4,811,052)
Ending balance, shares at Mar. 31, 2020 5,000,000 2,250 379,742,524        
Ending balance, amount at Mar. 31, 2020 $ 500 $ 0 $ 37,975 $ 43,533,242 $ (46,427,396) $ (82,101) $ (2,937,780)